Abrocitinib-(CIBINQO)- (Jan 2022)- To treat refractory atopic dermatitis

Drug Name:
Abrocitinib-(CIBINQO)- (Jan 2022)- To treat refractory atopic dermatitis

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation